Allan B. Schwartz

1.1k total citations
36 papers, 773 citations indexed

About

Allan B. Schwartz is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Hematology. According to data from OpenAlex, Allan B. Schwartz has authored 36 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 8 papers in Nephrology and 7 papers in Hematology. Recurrent topics in Allan B. Schwartz's work include Dialysis and Renal Disease Management (5 papers), Erythropoietin and Anemia Treatment (5 papers) and Potassium and Related Disorders (5 papers). Allan B. Schwartz is often cited by papers focused on Dialysis and Renal Disease Management (5 papers), Erythropoietin and Anemia Treatment (5 papers) and Potassium and Related Disorders (5 papers). Allan B. Schwartz collaborates with scholars based in United States. Allan B. Schwartz's co-authors include Charles Swartz, G Onesti, Kwan E. Kim, Dennis E. Drayer, David Löwenthal, Marcus M. Reidenberg, Albert N. Brest, Joel L. Chinitz, Kwan Eun Kim and V. Paz-Martínez and has published in prestigious journals such as JAMA, Circulation and Annals of Internal Medicine.

In The Last Decade

Allan B. Schwartz

33 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allan B. Schwartz United States 15 308 170 162 150 115 36 773
Kwan E. Kim United States 12 247 0.8× 134 0.8× 100 0.6× 181 1.2× 105 0.9× 18 737
Anne B. Gould United States 11 269 0.9× 153 0.9× 142 0.9× 228 1.5× 108 0.9× 23 722
Bernhard Heintz Germany 15 202 0.7× 153 0.9× 72 0.4× 141 0.9× 104 0.9× 56 759
K. H. Rahn Germany 18 603 2.0× 231 1.4× 108 0.7× 151 1.0× 172 1.5× 56 1.2k
Mario Usberti Italy 16 140 0.5× 227 1.3× 166 1.0× 425 2.8× 214 1.9× 36 867
Federico Bertocchi Italy 18 665 2.2× 63 0.4× 132 0.8× 97 0.6× 136 1.2× 31 1.1k
Hollenberg Nk United States 14 199 0.6× 129 0.8× 77 0.5× 110 0.7× 143 1.2× 32 579
Margus Annuk Sweden 8 230 0.7× 83 0.5× 85 0.5× 261 1.7× 112 1.0× 13 691
Gen Yasuda Japan 15 317 1.0× 104 0.6× 168 1.0× 220 1.5× 123 1.1× 73 790
Gerd Bönner Germany 17 470 1.5× 118 0.7× 121 0.7× 36 0.2× 105 0.9× 82 886

Countries citing papers authored by Allan B. Schwartz

Since Specialization
Citations

This map shows the geographic impact of Allan B. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan B. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan B. Schwartz more than expected).

Fields of papers citing papers by Allan B. Schwartz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan B. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan B. Schwartz. The network helps show where Allan B. Schwartz may publish in the future.

Co-authorship network of co-authors of Allan B. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of Allan B. Schwartz. A scholar is included among the top collaborators of Allan B. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan B. Schwartz. Allan B. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwartz, Allan B., Andrew P. Steenhoff, T Chadborn, et al.. (2013). Outcomes in HIV-infected adults with tuberculosis at clinics with and without co-located HIV clinics in Botswana. The International Journal of Tuberculosis and Lung Disease. 17(10). 1298–1303. 5 indexed citations
2.
Schwartz, Allan B., et al.. (2009). Volatility of elevated serum ferritin in anemic hemodialysis patients. Journal of Nephrology. 22(4). 553–560.
3.
Schwartz, Allan B., et al.. (2005). Chronic Vascular Inflammation in Patients With Type 2 Diabetes. Diabetes Care. 28(2). 379–384. 66 indexed citations
4.
Schwartz, Allan B., et al.. (1992). RBC improved survival due to recombinant human erythropoietin explains effectiveness of less frequent, low dose subcutaneous therapy.. PubMed. 38(5). 283–9. 13 indexed citations
5.
Schwartz, Allan B., et al.. (1991). Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietin.. PubMed. 23(2). 1827–30. 13 indexed citations
6.
Soslau, Gerald, et al.. (1990). Desmopressin-Induced Improvement in Bleeding Times in Chronic Renal Failure Patients Correlates with Platelet Serotonin Uptake and ATP Release. The American Journal of the Medical Sciences. 300(6). 372–379. 16 indexed citations
7.
Schwartz, Allan B., et al.. (1990). Heparin Free Hemodialysis Does Not Cause Fibrin Consumptive Coagulopathy and Maintains Alternate Pathway Complement Activation. ASAIO Transactions. 36(2). 86–89. 2 indexed citations
8.
Soslau, Gerald, et al.. (1990). Selective Reduction of Serotonin Storage and ATP Release in Chronic Renal Failure Patient Platelets. American Journal of Hematology. 35(3). 171–178. 40 indexed citations
9.
Katz, S, et al.. (1989). Lack of Antibodies to Legionella Pneumophila and Legionella Micdadei in Hemodialysis Patients. Scandinavian Journal of Urology and Nephrology. 23(2). 151–152. 2 indexed citations
10.
Goldstein, Steven, et al.. (1988). Contamination of Perfused Donor Kidneys by Starch from Surgical Gloves. American Journal of Clinical Pathology. 90(1). 81–84. 4 indexed citations
11.
Schwartz, Allan B., et al.. (1987). Delayed Traumatic Arteriovenous Fistula following Hemodialysis Vascular Catheterization. ˜The œNephron journals/Nephron journals. 46(4). 350–352. 2 indexed citations
13.
Schwartz, Allan B., et al.. (1986). Continuous Arteriovenous Hemofiltration for the Treatment of Anasarca and Acute Renal Failure in Severely Burned Patients. ASAIO Transactions. 32(1). 401–404. 13 indexed citations
14.
Nestico, Pasquale F., Nicholas L. DePace, Morris N. Kotler, et al.. (1983). Calcium phosphorus metabolism in dialysis patients with and without mitral anular calcium. The American Journal of Cardiology. 51(3). 497–500. 33 indexed citations
15.
Damjanov, Ivan, Sheila Moriber Katz, Edison Catalano, Daniel Mason, & Allan B. Schwartz. (1979). Myelolipoma in a heterotopic adrenal gland. Light and electron microscopic findings. Cancer. 44(4). 1350–1356. 27 indexed citations
16.
Schwartz, Allan B.. (1978). Potassium-Related Cardiac Arrhythmias and Their Treatment. Angiology. 29(3). 194–205. 38 indexed citations
17.
Schwartz, Allan B.. (1978). Conversion of External Arteriovenous Hemodialysis Shunt to Internal Fistula. JAMA. 239(17). 1782–1782. 1 indexed citations
18.
Kim, Kwan Eun, G Onesti, Allan B. Schwartz, Joel L. Chinitz, & Charles Swartz. (1972). Hemodynamics of Hypertension in Chronic End-Stage Renal Disease. Circulation. 46(3). 456–464. 75 indexed citations
19.
Schwartz, Allan B., Robert H. Seller, G Onesti, et al.. (1969). Pharmacodynamic Effects of a New Potassium‐Sparing Diuretic, Amiloride. 9(4). 217–223. 5 indexed citations
20.
Onesti, G, Allan B. Schwartz, Kwan E. Kim, Charles Swartz, & Albert N. Brest. (1969). Pharmacodynamic Effects of a New Antihypertensive Drug, Catapres (ST-155). Circulation. 39(2). 219–228. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026